Conversely, by focusing on a correlation between high FOXC2 and Cadherin switch, we showed that high expression of FOXC2 in clinical HCC samples is involved in EMT-related tumor aggressiveness. The gene discussed is FOXC2; the disease is hepatocellular carcinoma.